Skip to content

Hypermobility
& EDS

A decade of research behind the treatment.

We support patients with hypermobility and Ehlers-Danlos Syndrome (EDS) with a multi-disciplinary approach that combines advanced biomechanics, movement rehabilitation, and evidence-based support strategies, built on doctoral research and peer-reviewed publication, not on interest alone.

EDS - Mo on stage
Symptomatic hypermobility

Being bendy is not the problem. Being bendy and sore is.

Hypermobility Spectrum Disorder (HSD) and hypermobile Ehlers-Danlos Syndrome (hEDS) together describe symptomatic hypermobility: joint hypermobility presenting with pain, joint instability and soft tissue injury, and often a broad range of systemic comorbidities. The chronic pain and functional impairment that follow can significantly limit what someone can take part in. That definition is drawn from Dr Mo’s doctoral research.

The record

Ten years of work in one field

Very few clinicians in Australia work in symptomatic hypermobility at this level. This is the trail that sits behind that.

  1. 2017

    The research begins

    Dr Mo starts researching symptomatic hypermobility in children, and enrols in a doctoral program while continuing to practise, the clinical work and the research running alongside each other from the outset.

  2. 2021

    A systematic review of the evidence

    Published in BMC Pediatrics: a systematic review of the outcome measures used to track change over time in symptomatic children with hypermobility: establishing what the field could actually measure before setting out to improve it.

  3. 2022

    Published in JMIR Pediatrics and Parenting

    Validation of an electronic pain scale against the traditional paper scale in 43 children with HSD and hEDS, so pain in this group can be tracked reliably between appointments.

  4. 2022

    Invited to speak in Rome

    Invited speaker at the EDS International Conference, the field’s main global gathering of clinicians and researchers.

  5. 2023

    Orthoses shown to reduce pain in hypermobile children

    Published in the International Journal of Environmental Research and Public Health: after one month wearing custom orthoses, children reported a mean pain reduction of 27 points out of 100, alongside improved quality of life, walking distance and fatigue.

  6. 2024

    Awarded PhD in joint hypermobility

    Dr Mo’s doctorate at the University of Newcastle, on the impact of podiatric management for children and adolescents with generalised joint hypermobility and lower limb pain.

  7. 2025

    Mapping how hypermobile children actually move

    A case-control study of 27 children with generalised joint hypermobility against 25 matched peers, finding significant differences in hip rotation, Q-angle, ankle range of motion and foot posture: the mechanics that treatment has to account for.

  8. 2025

    Speaking at the Gold Coast

    Invited speaker at the Australian podiatry conference, and publication of the doctoral thesis behind this work: assessing and managing symptomatic hypermobility in children and adolescents.

  9. 2026

    SEP · 18

    Charles Sturt University podiatry symposium

    Upcoming

    Invited speaker, September 2026.

  10. 2026

    SEP · 12

    Musculoskeletal Podiatry in Focus: APodA professional development series

    Upcoming

    Presenting Prescribing Foot Orthoses with Confidence: The Flat and Cavus Foot, and leading the workshop Under the Hood: Evaluating Orthosis Features and How They Work. Event details

  11. 2026

    NOV

    Australian Podiatry Association paediatric conference

    Upcoming

    Speaker, November 2026.

About_us_imge
Credentials

Where the expertise comes from

  • PhD

    Joint hypermobility

    University of Newcastle, on podiatric management for children and adolescents with generalised joint hypermobility.

  • 4

    Peer-reviewed papers

    In international journals, on hypermobility, pain measurement and lower limb biomechanics.

  • 2

    Invited conference talks

    The EDS International Conference in Rome, 2022, and the Australian podiatry conference on the Gold Coast, 2025.

  • Vice Chair

    Australian Paediatric Podiatry Group

    Vice Chair, previously Chair, of the national group for paediatric podiatry.

The Ehlers-Danlos Society

Listed in the international practitioner directory

Dr Mo is a member of The Ehlers-Danlos Society’s International Consortium and is listed in its practitioner directory, one of the routes patients with EDS and HSD use to find clinicians who already know the condition. He collaborates monthly with members of the Consortium worldwide.

  • Member, Ehlers-Danlos Society International Consortium
  • Monthly collaboration with international EDS researchers and clinicians
  • Vice Chair, previously Chair, Australian Paediatric Podiatry Group
  • Previously contingent consultant, The Children’s Hospital Westmead
  • Member, Sports Medicine Australia and the Australian Podiatry Association
Published research

The work, in the journals

Every paper below is publicly available. Follow the link and read it yourself.

  1. 2025

    Lower Limb Biomechanical Observations in Hypermobile Children: An Exploratory Case–Control Study

    Maarj M, et al.

    International Journal of Environmental Research and Public Health, 2025;22(12):1776

    27 children with generalised joint hypermobility compared against 25 matched controls. Internal hip rotation, Q-angle, ankle range of motion and foot posture index were all significantly higher in the hypermobile group.

    Read More

  2. 2024

    Assessment and management of children and adolescents with symptomatic hypermobility

    Maarj M.

    Doctoral thesis, University of Newcastle, published November 2025

    The thesis behind the work above: assessing and managing symptomatic hypermobility in children and adolescents.

    Read More

  3. 2025

    Physical and Mechanical Therapies for Lower Limb Problems in Children With Juvenile Idiopathic Arthritis: A Systematic Review With Meta-Analysis

    Fellas A, Hawke F, Maarj M, Singh-Grewal D, Santos D, Coda A.

    Journal of Foot and Ankle Research, 2025. PMID 41189076

    Eleven randomised trials pooled. Foot orthoses produced a statistically and clinically significant reduction in child- and parent-reported foot and ankle pain at three months; physical therapies such as Pilates and underwater exercise reduced lower limb pain over the same period.

    Read More

  4. 2023

    The Impact of Podiatric Intervention on the Quality of Life and Pain in Children and Adolescents with Hypermobility

    Maarj M, Pacey V, Tofts L, Clapham M, Coda A.

    International Journal of Environmental Research and Public Health, 2023;20(17):6623

    After one month wearing custom orthoses, children reported reduced pain (mean VAS −27/100), and improved quality of life, six-minute walk distance and fatigue.

    Read More

  5. 2022

    Emerging Tools to Capture Self-Reported Acute and Chronic Pain Outcome in Children and Adolescents: A Literature Review

    Turnbull A, Sculley D, Santos D, Maarj M, Chapple L, Gironès X, Fellas A, Coda A.

    Medical Sciences, 2022;10(1):6. PMID 35225940

    Reviewed the emerging digital tools for capturing children’s own reports of acute and chronic pain, finding that real-time electronic capture reduces recall bias compared with paper-based scales.

    Read More

  6. 2022

    Validation of an Electronic Visual Analog Scale App for Pain Evaluation in Children and Adolescents With Symptomatic Hypermobility: Cross-sectional Study

    Maarj M, Pacey V, Tofts L, Clapham M, Gironès Garcia X, Coda A.

    JMIR Pediatrics and Parenting, 2022;5(4):e41930

    Validated a mobile app pain scale against the traditional paper scale in 43 children with HSD and hEDS, so pain can be tracked reliably between appointments.

    Read More

  7. 2021

    Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review

    Maarj M, Coda A, Tofts L, Williams C, Santos D, Pacey V.

    BMC Pediatrics, 2021. PMID 34839813

    Synthesised the outcome measures used in longitudinal and interventional studies of children with generalised joint hypermobility and lower limb symptoms: mapping what the field could reliably measure.

    Read More

In the clinic

What that research changes for you

The point of the work is what happens in the room. Research into how hypermobile limbs load is what a plan gets built from.

  • Assess the whole chain

    A biomechanical assessment of how the foot, ankle, knee and hip move and load, not the painful joint in isolation.

  • Support where it helps

    Prescription orthoses, and where more control is needed, custom bracing such as the Richie Brace or a foot orthosis, prescribed to the assessment.

  • Build control

    Strength and conditioning so the muscles around a hypermobile joint take on more of the work the ligaments are not doing.

Children & adolescents

“They’ll grow out of it.” Sometimes.

Paediatric hypermobility is where this practice has done most of its research. Growing children with symptomatic hypermobility are often told to wait. Sometimes waiting is right. Where pain is limiting what a child can join in with, it is worth assessing rather than waiting, which is precisely what the 2023 study set out to measure.

This page is general information about our work in hypermobility and EDS, not a diagnosis and not personal medical advice. Hypermobility presents differently in every person. Speak with a podiatrist, your GP or your specialist about your own situation.